Investors Buy Shares of UnitedHealth Group (UNH) on Weakness

Investors bought shares of UnitedHealth Group Inc (NYSE:UNH) on weakness during trading on Tuesday. $197.45 million flowed into the stock on the tick-up and $143.25 million flowed out of the stock on the tick-down, for a money net flow of $54.20 million into the stock. Of all equities tracked, UnitedHealth Group had the 32nd highest net in-flow for the day. UnitedHealth Group traded down ($2.71) for the day and closed at $226.66

UNH has been the subject of a number of analyst reports. Zacks Investment Research upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $267.00 price target for the company in a research note on Saturday, January 20th. Goldman Sachs Group assumed coverage on shares of UnitedHealth Group in a research note on Wednesday, January 3rd. They set a “buy” rating and a $269.00 price target for the company. Credit Suisse Group lifted their target price on shares of UnitedHealth Group from $252.00 to $260.00 and gave the company an “outperform” rating in a research note on Wednesday, January 17th. Cantor Fitzgerald reiterated a “buy” rating and issued a $235.00 target price on shares of UnitedHealth Group in a research note on Monday, December 25th. Finally, Piper Jaffray Companies lifted their target price on shares of UnitedHealth Group to $242.00 and gave the company an “overweight” rating in a research note on Wednesday, November 29th. Two investment analysts have rated the stock with a hold rating and twenty-six have assigned a buy rating to the company. The company has a consensus rating of “Buy” and an average target price of $243.22.

The company has a debt-to-equity ratio of 0.58, a quick ratio of 0.73 and a current ratio of 0.73. The stock has a market capitalization of $218,170.00, a price-to-earnings ratio of 23.70, a price-to-earnings-growth ratio of 1.34 and a beta of 0.70.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 earnings per share for the quarter, beating analysts’ consensus estimates of $2.50 by $0.09. The business had revenue of $52.06 billion during the quarter, compared to analyst estimates of $51.57 billion. UnitedHealth Group had a net margin of 5.25% and a return on equity of 21.29%. UnitedHealth Group’s revenue for the quarter was up 9.5% compared to the same quarter last year. During the same quarter last year, the business posted $2.11 earnings per share. analysts anticipate that UnitedHealth Group Inc will post 12.51 EPS for the current year.

The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 20th. Investors of record on Friday, March 9th will be issued a $0.75 dividend. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.33%. The ex-dividend date is Thursday, March 8th. UnitedHealth Group’s dividend payout ratio is currently 31.58%.

In other UnitedHealth Group news, Director Gail R. Wilensky sold 5,600 shares of UnitedHealth Group stock in a transaction on Wednesday, November 29th. The shares were sold at an average price of $223.31, for a total transaction of $1,250,536.00. Following the completion of the sale, the director now owns 61,137 shares of the company’s stock, valued at approximately $13,652,503.47. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Larry C. Renfro sold 22,598 shares of UnitedHealth Group stock in a transaction on Friday, December 15th. The stock was sold at an average price of $221.75, for a total transaction of $5,011,106.50. Following the sale, the chief executive officer now directly owns 195,314 shares of the company’s stock, valued at approximately $43,310,879.50. The disclosure for this sale can be found here. In the last three months, insiders sold 53,396 shares of company stock valued at $12,262,067. 0.89% of the stock is currently owned by company insiders.

A number of institutional investors and hedge funds have recently added to or reduced their stakes in UNH. Beach Investment Management LLC. acquired a new stake in UnitedHealth Group during the 2nd quarter worth $556,000. Cobblestone Capital Advisors LLC NY grew its holdings in UnitedHealth Group by 4.6% during the 2nd quarter. Cobblestone Capital Advisors LLC NY now owns 1,799 shares of the healthcare conglomerate’s stock worth $334,000 after acquiring an additional 79 shares during the period. GAM Holding AG grew its holdings in shares of UnitedHealth Group by 7.7% in the 2nd quarter. GAM Holding AG now owns 198,107 shares of the healthcare conglomerate’s stock valued at $36,733,000 after buying an additional 14,236 shares during the period. Sumitomo Mitsui Trust Holdings Inc. grew its holdings in shares of UnitedHealth Group by 2.3% in the 2nd quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 3,168,251 shares of the healthcare conglomerate’s stock valued at $587,457,000 after buying an additional 72,543 shares during the period. Finally, MUFG Americas Holdings Corp grew its holdings in shares of UnitedHealth Group by 11.8% in the 2nd quarter. MUFG Americas Holdings Corp now owns 57,651 shares of the healthcare conglomerate’s stock valued at $10,689,000 after buying an additional 6,088 shares during the period. 85.65% of the stock is owned by hedge funds and other institutional investors.

ILLEGAL ACTIVITY WARNING: This story was originally posted by The Lincolnian Online and is the sole property of of The Lincolnian Online. If you are accessing this story on another publication, it was copied illegally and reposted in violation of United States and international copyright and trademark legislation. The legal version of this story can be accessed at https://www.thelincolnianonline.com/2018/02/22/investors-buy-shares-of-unitedhealth-group-unh-on-weakness.html.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply